IRVING, Texas, Aug. 10, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, announced today that OU Health Stephenson Cancer Center has joined the Caris Precision Oncology Alliance™ (POA). The POA is a growing network of leading cancer centers across the globe that collaborate to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve the clinical outcomes for cancer patients.
- Located on the University of Oklahoma Health Sciences Center campus in Oklahoma City, Stephenson Cancer Center is the state's only National Cancer Institute (NCI)-Designated Cancer Center, providing a critical resource for patients seeking research-driven, patient-centered, multidisciplinary treatment.
- "Stephenson Cancer Center is pleased to join the Caris Precision Oncology Alliance," said Kathleen Moore, M.D., Professor of Gynecologic Oncology, Virginia Kerley Cade Endowed Chair in Cancer Developmental Therapeutics, and Director of the Oklahoma TSET Phase 1 program.
- "We are excited to welcome OU Health Stephenson Cancer Center to the growing Precision Oncology Alliance network," said Chadi Nabhan , M.D., MBA, FACP, Chairman of the Caris Precision Oncology Alliance.
- OU Health Stephenson Cancer Center is Oklahoma's only National Cancer Institute-Designated Cancer Center.